Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Progression-Free Survival”

280 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 280 results

Not applicableStudy completedNCT03601689
What this trial is testing

Predictive Factors of Disease-free Survival After Complete Pathological Response to Neoadjuvant Radiotherapy in Rectal Adenocarcinoma

Who this might be right for
Rectal Neoplasms
Moroccan Society of Surgery 84
Not applicableLooking for participantsNCT04805255
What this trial is testing

A Neurocognitive Study in Patients With Brain Oligometastases Receiving Hypofractionated SRT

Who this might be right for
Brain Metastases, Adult
Chang Gung Memorial Hospital 135
Not applicableLooking for participantsNCT07120529
What this trial is testing

Minimally Invasive Surgery Versus Open Radical Hysterectomy in Presumably Early Stage Cervical Cancer: a Retrospective Multicenter Non-inferiority Study Comparing Overall and Progression-free Survival.

Who this might be right for
Cervical CancerHysterectomy
Medical University of Silesia 300
Testing effectiveness (Phase 2)Ended earlyNCT03729297
What this trial is testing

Cabozantinib in Advanced Salivary Gland Cancer Patients

Who this might be right for
Salivary Gland Cancer
Radboud University Medical Center 25
Testing effectiveness (Phase 2)Study completedNCT05455424
What this trial is testing

Niraparib Efficacy in Patient With Unresectable Mesothelioma

Who this might be right for
Mesothelioma, Malignant
University Hospital Southampton NHS Foundation Trust 88
Testing effectiveness (Phase 2)UnknownNCT03799094
What this trial is testing

Vitamin C and Tyrosine Kinase Inhibitor in Lung Cancer Patients With Epidermal Growth Factor Receptor Mutations

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Clifford Hospital, Guangzhou, China 150
Large-scale testing (Phase 3)Ended earlyNCT01200212
What this trial is testing

Study to Determine the Efficacy of a Taxane and Bevacizumab With or Without Capecitabine as First Line Chemotherapy in Patients With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
GBG Forschungs GmbH 432
Testing effectiveness (Phase 2)Ended earlyNCT00940875
What this trial is testing

Tarceva (Erlotinib) in Sequential Combination With Gemcitabine as First Line Therapy in Patients With Advanced Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
Hoffmann-La Roche 54
Early research (Phase 1)Looking for participantsNCT06624371
What this trial is testing

Atovaquone Combined With Radiation in Children With Malignant Brain Tumors

Who this might be right for
High-grade GliomaMedulloblastomaDiffuse Intrinsic Pontine Glioma+1 more
Emory University 18
Testing effectiveness (Phase 2)Temporarily pausedNCT02008019
What this trial is testing

A Phase II Study of EVEROLIMUS in Patients With Primary or Relapsed Chondrosarcomas

Who this might be right for
Chondrosarcoma
Centre Leon Berard 57
Not applicableLooking for participantsNCT06215495
What this trial is testing

A Novel Target Delineation Scheme in High-grade Glioma Patients: a Randomized Single-blind Clinical Trial

Who this might be right for
Radiation ToxicityMRI Simulated PositioningHigh Grade Glioma+2 more
Zhujiang Hospital 88
Not applicableUnknownNCT04495309
What this trial is testing

Metastases-directed Radiotherapy in Addition to Standard Systemic Therapy in Patients With Oligometastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
University Hospital Schleswig-Holstein 564
Large-scale testing (Phase 3)Looking for participantsNCT04876651
What this trial is testing

The Present Study Aims to Compare Patients Who Receive the Investigational Product (177Lu-DOTA-rosopatamab) Plus Standard of Care, in Comparison to Standard of Care Only

Who this might be right for
Metastatic Prostate Cancer
Telix Pharmaceuticals (Innovations) Pty Ltd 392
Testing effectiveness (Phase 2)Looking for participantsNCT04933669
What this trial is testing

Prospective Multicenter Clinical Study of Neoadjuvant Imatinib Mesylate for Gastrointestinal Stromal Tumors

Who this might be right for
Progression-free SurvivalGastrointestinal Stromal TumorNeoadjuvant
First Affiliated Hospital of Zhejiang University 122
Not applicableUnknownNCT05862051
What this trial is testing

RESOLUTE Trial Aims to Investigate the Value of Adding Local Ablative Treatment to Standard Systemic Treatment for Unresectable Oligometastatic Colorectal Cancer

Who this might be right for
Colorectal CancerOligometastatic Disease
Australasian Gastro-Intestinal Trials Group 75
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07405736
What this trial is testing

Lubiprostone Combined With Maintenance Therapy for Prevention of Postoperative Recurrence in Peritoneal Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer MetastaticPeritoneal (Metastatic) CancerPeritoneal Metastasis+2 more
Sun Yat-sen University 124
Testing effectiveness (Phase 2)Study completedNCT01110668
What this trial is testing

Evaluation of Nilotinib In Patients With Advanced Gastrointestinal Stromal Tumor (GIST)

Who this might be right for
Gastrointestinal Stromal Tumor
Novartis Pharmaceuticals 2
Testing effectiveness (Phase 2)Study completedNCT03769935
What this trial is testing

Maintenance Therapy for Small-cell Lung Cancer

Who this might be right for
Progression Free Survival
Qingdao Central Hospital 90
Not applicableStudy completedNCT06629714
What this trial is testing

Impact of Pretreatment Emotional Distress on Survival and the Predictive Role of Peripheral Biomarkers in Immunotherapy Response Among Gastroesophageal and Lung Cancer Patients

Who this might be right for
Non Small Cell Lung CancerImmune Checkpoint InhibitorsInflammation+5 more
Anhui Medical University 196
Not applicableActive Not RecruitingNCT07075939
What this trial is testing

Centralization and Oncologic Outcomes in Ovarian Cancer

Who this might be right for
Epithelial Ovarian CancerOvarian NeoplasmsAdvanced Ovarian Cancer
Azienda USL Reggio Emilia - IRCCS 200
Load More Results